GloriaPHeresiMD

Pediatric Infectious Disease • Houston, TX

HIV/AIDS Pediatrics

Professor, Pediatrics, University of Texas Medical School, Houston

Join to view full profile

Dr. Heresi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Heresi's full profile

Already have an account?

Office
6431 Fannin St
Houston, TX 77030
Phone+1 713-500-5714

Fax+1 713-500-5688

Education & Training

University of Texas Southwestern Medical CenterFellowship, Pediatric Infectious Diseases, 1993 - 1996
University of MarylandResidency, Pediatrics, 1989 - 1991
University of ChileClass of 1975

Certifications & Licensure

TX State Medical License 1996 - 2026
MD State Medical License 1992 - 1998
American Board of Pediatrics Pediatric Infectious Diseases

Clinical Trials

Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005) Start of enrollment: 2012 Nov 29
Completed
Phase 4
Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006) Start of enrollment: 2013 Sep 13
Completed
Phase 3
Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants Start of enrollment: 2013 Aug 26
Terminated
Phase 2, Phase 3
Antibiotic Safety (SCAMP) Start of enrollment: 2013 Dec 01
Completed
Phase 2, Phase 3
Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV Start of enrollment: 2014 Jan 16
Recruiting
Phase 2, Phase 3
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) Start of enrollment: 2020 Mar 05
Recruiting
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

107 citations
Controlled trial of zinc supplementation during recovery from malnutrition: effects on growth and immune function.
Carlos Castillo-Durán, Gloria P Heresi, Mauro Fisberg, Ricardo Uauy
The American Journal of Clinical Nutrition. 1987-03-01
84 citations
Community-associated methicillin-resistant Staphylococcus aureus in pediatric patients.
Theresa J. Ochoa, John F. Mohr, Audrey Wanger, James R. Murphy, Gloria P Heresi
Emerging Infectious Diseases. 2005-06-01
16 citations
Double-blind controlled crossover trial of 4% intranasal sodium cromoglycate solution in patients with seasonal allergic rhinitis.
Ranjit Kumar Chandra, Gloria P Heresi, G Woodford
Annals of Allergy. 1982-09-01

Authored Content

Transverse Myelitis and Guillain-Barré Syndrome Associated with Cat-Scratch Disease, Texas, USA, 2011August 2018